Profile
AARD VRTX REGN ALNY SGEN ARGX
Company Name Aardvark Therapeutics, Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $251.89M $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 0.02K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Tien-Li Lee Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
AARD VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
AARD VRTX REGN ALNY SGEN ARGX
Last Close $11.6 $469.55 $547.93 $322.81 $228.74 $577.92
High 52 $17.11 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 - $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -32.2 % -9.13 % -54.41 % -2.74 % 0 % -13.97 %
Price vs. 52 Week Low 0 % 18.38 % 13.46 % 43.74 % 0 % 25.36 %
Total Return
AARD VRTX REGN ALNY SGEN ARGX
1 Month Return 4.79 % 6.24 % 7.65 % 4.54 % 0 % 6.88 %
3 Month Return 65.71 % -4 % -2.7 % 37.62 % 0 % -3.07 %
6 Month Return 0 % 11.27 % -19.61 % 31.08 % 0 % -9.77 %
9 Month Return 0 % -5.85 % -45.09 % 8.8 % 0 % 6.37 %
YTD Return 0 % 16.6 % -23.08 % 37.18 % 0 % -6.03 %
1 Year Return 0 % -3.85 % -49.53 % 34.49 % 0 % 24.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AARD VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2202.36 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
AARD VRTX REGN ALNY SGEN ARGX
Asset Growth 635.64 % -0.87 % 36.55 %
Gross Profit Growth - 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth -205.7 % -93.69 % 128.87 %
Net Income Growth -185.63 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share -14.44 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share -14.44 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -14.44 % 33.84 % 938.02 %
Operating Income Growth -207.28 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -210.56 % -113.93 % 80.31 %
Operating 3 Year CFG -29.34 % -118.65 % 88.36 %
Operating 5 Year CFG -29.34 % -131.3 % -135.21 %
Operating 10 Year CFG -29.34 % 12.43 % -64 %
EPS Growth -183.93 % -114.8 % 369.77 %
EPS Diluted Growth -183.93 % -114.97 % 347.67 %
Book Value Per Share -57.01 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 294.71 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 294.71 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 294.71 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 380.86 % 116.42 % 95.27 %
Free Cash Flow Growth -212.43 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
AARD VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -15.48 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -1285.33 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -18.04 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 89.24 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -3336.91 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -1.84 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -1.84 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 1146.37 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -3336.91 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -10.39 -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -6.32 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -6.32 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
AARD VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.02B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.02B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -1.59 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
AARD VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.13B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $-0.05B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.01B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.08B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
AARD VRTX REGN ALNY SGEN ARGX
Net Income $-0.02B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.425
ABCL AbCellera Biologics Inc. 3.895
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.63
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.5
ABPWW 0.0225
ABSI Absci Corporation 2.885
ABUS Arbutus Biopharma Corporation 3.135
ABVC ABVC BioPharma, Inc. 3.57
ABVX Abivax SA American Depositary Shares 10.32
ACAD ACADIA Pharmaceuticals Inc. 22.57
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7911
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.75
ACIU AC Immune SA 2.07
ACLX Arcellx, Inc. 70.95
ETFs With Exposure to AARD
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00147 223.84
VTI Vanguard Total Stock Market Index Fund 0 309.245
IWN iShares Russell 2000 Value ETF 0.00241 164.29
IWO iShares Russell 2000 Growth ETF 0.00208 294.73
VXF Vanguard Extended Market Index Fund 0 198.5
VTHR Vanguard Russell 3000 Index Fund 0 277.43
IWC iShares Micro-Cap ETF 0.01856 134.365
VTWV Vanguard Russell 2000 Value Index Fund 0 145.03
VTWG Vanguard Russell 2000 Growth Index Fund 0 215.13
VTWO Vanguard Russell 2000 Index Fund 0 90.49
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 42.79
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.51
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.99
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.99
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 148.84
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 148.85
VEMPX Vanguard Extended Market Index InstlPlus 0 367.31
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 280.66
RSSL Global X Funds 0 87.93
Unlock